To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia - Related Studies

To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

This study has been completed.

Study NCT00007774. Last updated on February 2, 2007. Information provided by Department of Veterans Affairs

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Schizophrenia
		Schizoaffective Disorder

2	Additional conditions recognized in this trial
		Psychotic Disorders

3	More general conditions related to this trial
		Mental Disorders
		Schizophrenia and Disorders with Psychotic Features

4	Interventions listed in this trial
		Olanzapine (5 mg to 20 mg/day
		Haloperidol (5 mg to 20 mg/day)

5	Additional drug interventions recognized in this trial
		Haloperidol
		Haloperidol decanoate
		Olanzapine

6	More general drug interventions related to this trial
		Anti-Dyskinesia Agents
		Antiemetics
		Antipsychotic Agents
		Autonomic Agents
		Central Nervous System Agents
		Central Nervous System Depressants
		Dopamine Agents
		Dopamine Antagonists
		Gastrointestinal Agents
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Uptake Inhibitors
		Therapeutic Uses
		Tranquilizing Agents

7	Sponsors listed in this trial
		Department of Veterans Affairs
		Eli Lilly and Company